There was excellent interobserver agreement in evaluating Fontan-associated liver disease nodules at hepatic contrast-enhanced US, and diagnoses at contrast-enhanced US agreed with the majority of biopsy diagnoses, including malignancy.
Mittelstein et al. (Fri,) studied this question.